Expres2ion Biotech Holding AB (EXPRS2) - Financials, balance sheet (annual)

Main market

Access this stock data via API

Expres2ion Biotech Holding AB

Financials

Balance sheet

Fiscal date	2024	2023	2022	2021
Total assets	104.5M	78.7M	137.4M	152.0M
Current assets	95.0M	68.7M	131.9M	146.5M
Cash	81.5M	57.6M	111.0M	37.1M
Cash equivalents	—	—	—	—
Cash and cash equivalents	81.5M	57.6M	111.0M	37.1M
Other short term investments	—	—	—	101.8M
Accounts receivable	1.2M	950K	826K	1.6M
Other receivables	3.9M	1.4M	1.7M	2.0M
Inventory	—	—	—	—
Prepaid assets	—	515K	10.2M	479K
Restricted cash	—	—	—	—
Assets held for sale	—	—	—	—
Hedging assets	—	—	—	—
Other current assets	—	—	—	—
Non current assets	9.6M	10.0M	5.4M	5.5M
Properties	—	—	—	—
Land and improvements	—	—	—	—
Machinery furniture equipment	1.5M	8.2M	6.2M	5.4M
Construction in progress	—	—	—	—
Leases	—	—	—	—
Accumulated depreciation	—	-6.4M	-5.3M	-4.2M
Goodwill	2.1M	2.5M	3.0M	3.1M
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	—	2.5M	3.0M	3.1M
Investments and advances	—	—	—	—
Other non current assets	—	16K	—	-1K
Total liabilities	40.1M	13.3M	34.0M	11.6M
Current liabilities	38.2M	11.4M	31.4M	7.5M
Accounts payable	8.5M	1.8M	12.2M	1.7M
Accrued expenses	—	—	—	—
Short term debt	360K	275K	1.8M	1.9M
Deferred revenue	—	—	—	—
Tax payable	—	—	—	—
Pensions	—	—	—	—
Other current liabilities	29.4M	9.3M	17.5M	3.9M
Non current liabilities	1.9M	1.9M	2.6M	4.1M
Long term provisions	—	—	—	—
Long term debt	—	1.4M	88K	191K
Provision for risks and charges	—	—	—	—
Deferred liabilities	428K	510K	608K	671K
Derivative product liabilities	—	—	—	—
Other non current liabilities	1.4M	—	1.9M	3.3M
Shareholders equity
Common stock	11.8M	5.7M	4.2M	3.5M
Retained earnings	—	—	—	—
Other shareholders equity	—	—	—	—
Total shareholders equity	64.4M	65.4M	103.3M	140.3M
Additional paid in capital	269.6M	529.8M	338.7M	266.2M
Treasury stock	—	—	—	—
Minority interest	—	—	—	—